Middle East: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Middle East

The Middle Eastern prophylactic medicaments containing insulin market amounted to $X in 2022, flattening at the previous year. The total consumption indicated buoyant growth from 2012 to 2022: its value increased at an average annual rate of +6.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -1.2% against 2020 indices. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Middle East

In value terms, prophylactic medicaments containing insulin production stood at $X in 2022 estimated in export price. The total production indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of +6.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -0.7% against 2020 indices. The pace of growth was the most pronounced in 2014 with an increase of 25% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in the Middle East

Prophylactic medicaments containing insulin exports surged to X tons in 2022, jumping by 251% compared with the year before. Over the period under review, exports showed a significant increase. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. In general, exports posted a significant expansion. The growth pace was the most rapid in 2018 when exports increased by 94%. The level of export peaked in 2022 and is expected to retain growth in the immediate term.

Exports by Country

The biggest shipments were from Turkey (X tons) and the United Arab Emirates (X tons), together finishing at 98% of total export.

From 2012 to 2022, the biggest increases were recorded for Turkey (with a CAGR of +73.7%).

In value terms, Turkey ($X) remains the largest prophylactic medicaments containing insulin supplier in the Middle East, comprising 69% of total exports. The second position in the ranking was held by the United Arab Emirates ($X), with a 27% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in Turkey amounted to +52.4%.

Export Prices by Country

In 2022, the export price in the Middle East amounted to $X per ton, reducing by -50.4% against the previous year. In general, the export price recorded a abrupt downturn. The most prominent rate of growth was recorded in 2020 when the export price increased by 48%. As a result, the export price reached the peak level of $X per ton. From 2021 to 2022, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Turkey ($X per ton), while the United Arab Emirates amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Turkey (-12.3%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in the Middle East

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported in the Middle East shrank to X tons, waning by -9% compared with 2021 figures. In general, imports, however, enjoyed buoyant growth. The most prominent rate of growth was recorded in 2013 with an increase of 42%. Over the period under review, imports reached the peak figure at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports totaled $X in 2022. Over the period under review, imports, however, continue to indicate a resilient increase. The pace of growth appeared the most rapid in 2017 when imports increased by 42% against the previous year. Over the period under review, imports hit record highs at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

Turkey was the largest importing country with an import of about X tons, which finished at 51% of total imports. Saudi Arabia (X tons) held the second position in the ranking, followed by Iran (X tons) and Israel (X tons). All these countries together held near 38% share of total imports. The following importers - the United Arab Emirates (X tons) and Oman (X tons) - each reached a 4.5% share of total imports.

Imports into Turkey increased at an average annual rate of +5.6% from 2012 to 2022. At the same time, Iran (+28.3%), Israel (+16.7%), Saudi Arabia (+13.7%), Oman (+12.0%) and the United Arab Emirates (+7.2%) displayed positive paces of growth. Moreover, Iran emerged as the fastest-growing importer imported in the Middle East, with a CAGR of +28.3% from 2012-2022. Iran (+13 p.p.), Saudi Arabia (+5.7 p.p.) and Israel (+2.5 p.p.) significantly strengthened its position in terms of the total imports, while Turkey saw its share reduced by -20.7% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest prophylactic medicaments containing insulin importing markets in the Middle East were Saudi Arabia ($X), Turkey ($X) and Iran ($X), together accounting for 69% of total imports.

Iran, with a CAGR of +24.3%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in the Middle East amounted to $X per ton, surging by 12% against the previous year. In general, the import price, however, showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2019 when the import price increased by 19%. As a result, import price reached the peak level of $X per ton. From 2020 to 2022, the import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the United Arab Emirates ($X per ton), while Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Oman (+4.1%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :